Assessing the Efficacy of the ARMOR Tool–Based Deprescribing Intervention for Fall Risk Reduction in Older Patients Taking Fall Risk–Increasing Drugs (DeFRID Trial): Protocol for a Randomized Controlled Trial

Autor: Rekha Priyadarshini, Madhavi Eerike, Sakthivadivel Varatharajan, Gomathi Ramaswamy, Gerard Marshall Raj, Jerin Jose Cherian, Priyadharsini Rajendran, Venugopalan Gunasekaran, Shailaja V Rao, Venu Gopala Rao Konda

Publikováno v: JMIR Research Protocols, Vol 13, p e55638 (2024)

BackgroundFalls in older patients can lead to serious health complications and increased health care costs. Fall risk–increasing drugs (FRIDs) are a group of drugs that may induce falls or increase the tendency to fall (ie, fall risk). Deprescribin

Externí odkaz: https://doaj.org/article/549a48cc137f4169906741560fd35d57

Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled studyResearch in context

Autor: Prasad S. Kulkarni, Abhijit Kadam, Sheela Godbole, Varsha Bhatt, Abhishek Raut, Sunil Kohli, Santanu Tripathi, Praveen Kulkarni, Rakhi Ludam, Madhav Prabhu, Ashish Bavdekar, Nithya J. Gogtay, Sushant Meshram, Tamilarasu Kadhiravan, Sonali Kar, D.H. Ashwath Narayana, Clarence Samuel, Govind Kulkarni, Abhay Gaidhane, Dipu Sathyapalan, Sidram Raut, Vijay Hadda, Hira Lal Bhalla, Chetanraj Bhamare, Abhijeet Dharmadhikari, Joyce S. Plested, Shane Cloney-Clarke, Mingzhu Zhu, Melinda Pryor, Stephanie Hamilton, Madhuri Thakar, Ashwini Shete, Manish Gautam, Nivedita Gupta, Samiran Panda, Umesh Shaligram, Cyrus S. Poonawalla, Balram Bhargava, Bhagwat Gunale, Dhananjay Kapse, Shubhangi A. Kanitkar, Arjun L. Kakrani, Srikanth P. Tripathy, Abhijit V. Tilak, Akshay A. Dhamne, Shahzad Beg Mirza, Prachi V. Athavale, Mandakini Bhowmik, Parag J. Ratnakar, Subodh Gupta, Vijayshri Deotale, Jyoti Jain, Ashwini Kalantri, Vineet Jain, Nidhi Goyal, Alok Arya, Temsunaro Rongsen-Chandola, Shreyasi Dasgupta, Pratibha Periera, Vanmathi A, Anand Kawade, Arunkumar Gondhali, Palvi Kudyar, Abhishek Singh, Ravi Yadav, Alina Alexander, Venugopalan Gunasekaran, Sekar Dineshbabu, P.C. Samantaray, H.S. Ravish, Deepshikha Kamra, Shilpa Gaidhane, Quazi Syed Zahiruddin, Merlin Moni, Anil Kumar, Ameet Dravid, Anant Mohan, Tejas Suri, Tejas K. Patel, Surekha Kishore, Rahul Choche, Deepak Ghatage, Sugam Salvi

Publikováno v: The Lancet Regional Health - Southeast Asia, Vol 10, Iss , Pp 100139- (2023)

Summary: Background: NVX-CoV2373, a Covid-19 vaccine was developed in the USA with ∼90% efficacy. The same vaccine is manufactured in India after technology transfer (called as SII-NVX-CoV2373), was evaluated in this phase 2/3 immuno-bridging study

Externí odkaz: https://doaj.org/article/82d9dafd89e042aabbf3940c237b71b1

Ready, Set, and Go!

Autor: Venugopalan Gunasekaran, Arvind Mathur

Publikováno v: Journal of the Indian Academy of Geriatrics, Vol 18, Iss 2, Pp 41-42 (2022)

Externí odkaz: https://doaj.org/article/25be2ffae8d949ddb5e65af8fbb99c76

Ageism in time of COVID-19

Autor: Venugopalan Gunasekaran

Publikováno v: Journal of the Indian Academy of Geriatrics, Vol 17, Iss 2, Pp 49-50 (2021)

Externí odkaz: https://doaj.org/article/a47d4752ee6d4ef48eb417301c474890

Outcome of older adults at risk of frailty

Autor: Aparajit Ballav Dey, Manicka Saravanan Subramanian, Venugopalan Gunasekaran, Vishwajeet Singh

Publikováno v: Aging Medicine, Vol 4, Iss 4, Pp 266-271 (2021)
Aging Medicine

Background The integral part of the definition of frailty is the outcome associated with it. Older adults at risk of frailty are in the process of becoming frail. This study looked at the clinical characteristics and outcomes of older adults at risk

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f25eda7287400aa37199cb6ce5bd344
https://doaj.org/article/042d0961616f4e99baa69739e11b8a2b